Dr. Martens PLC (DOCS) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.049x

Based on the latest financial reports, Dr. Martens PLC (DOCS) has a cash flow conversion efficiency ratio of -0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-16.10 Million ≈ $-1.96K USD) by net assets (GBX329.10 Million ≈ $40.04K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See DOCS cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Dr. Martens PLC - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Dr. Martens PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Dr. Martens PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dr. Martens PLC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Together Startup Network Ltd TA:TGTR	-0.149x
Solution Engineering Holdings Bhd KLSE:0093	0.004x
REVOLVE RENEW.POWER CORP. F:PM7	-0.348x
Newcity (Bangkok) Public Company Limited BK:NC	-0.037x
Calibre PA:ALWIN	0.240x
Nagambie Resources Ltd AU:NAG	-0.036x
Canterbury Resources Ltd AU:CBY	-0.060x
Vigor Kobo Co Ltd TWO:2733	-0.016x

Annual Cash Flow Conversion Efficiency for Dr. Martens PLC (2014–2025)

The table below shows the annual cash flow conversion efficiency of Dr. Martens PLC from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Dr. Martens PLC market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	GBX366.40 Million ≈ $44.58K	GBX196.30 Million ≈ $23.88K	0.536x	+17.49%
2024-03-31	GBX368.20 Million ≈ $44.80K	GBX167.90 Million ≈ $20.43K	0.456x	+138.44%
2023-03-31	GBX404.20 Million ≈ $49.18K	GBX77.30 Million ≈ $9.41K	0.191x	-65.96%
2022-03-31	GBX328.20 Million ≈ $39.93K	GBX184.40 Million ≈ $22.44K	0.562x	-30.25%
2021-03-31	GBX150.70 Million ≈ $18.34K	GBX121.40 Million ≈ $14.77K	0.806x	-53.22%
2020-03-31	GBX70.50 Million ≈ $8.58K	GBX121.40 Million ≈ $14.77K	1.722x	+125.83%
2019-03-31	GBX-8.40 Million ≈ $-1.02K	GBX56.00 Million ≈ $6.81K	-6.667x	-326.09%
2018-03-31	GBX-29.40 Million ≈ $-3.58K	GBX46.00 Million ≈ $5.60K	-1.565x	+18.13%
2017-03-31	GBX-18.00 Million ≈ $-2.19K	GBX34.40 Million ≈ $4.19K	-1.911x	+18.52%
2016-03-31	GBX-11.00 Million ≈ $-1.34K	GBX25.80 Million ≈ $3.14K	-2.345x	-109.48%
2015-03-31	GBX800.00K ≈ $97.34	GBX19.80 Million ≈ $2.41K	24.750x	+643.39%
2014-03-31	GBX1.51 Million ≈ $183.60	GBX5.02 Million ≈ $611.28	3.329x	--

About Dr. Martens PLC

LSE:DOCS UK Footwear & Accessories

Market Cap

$8.50 Million

GBX69.88 Billion GBX

Market Cap Rank

#27451 Global

#382 in UK

Share Price

GBX72.30

Change (1 day)

+2.55%

52-Week Range

GBX60.70 - GBX99.35

All Time High

GBX470.02